(Q77667993)
Statements
Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas (English)
J P Stevenson
R M Scher
R Kosierowski
S C Fox
M Simmonds
K S Yao
F Green
C Broom
S Z Fields
J B Krebs